Two Sigma Investments’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

Two Sigma Investments’s Portfolio DMRA Stock Details DMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-20,296	Closed	-$75.5K	–	4190
2025 Q3	$75.5K	Buy	+20,296	New	+$68.7K	﹤0.01%	3503
2023 Q3	–	Sell	-509	Closed	-$32.1K	–	3049
2023 Q2	$32.1K	Sell	509 -72	-12%	-$3.92K	﹤0.01%	2873
2023 Q1	$28.9K	Sell	581 -116	-17%	-$6.12K	﹤0.01%	2821
2022 Q4	$20K	Sell	697 -1,165	-63%	-$48.3K	﹤0.01%	2679
2022 Q3	$88K	Sell	1,862 -670	-26%	-$34K	﹤0.01%	2248
2022 Q2	$110K	Sell	2,532 -3,215	-56%	-$147K	﹤0.01%	2259
2022 Q1	$316K	Sell	5,747 -4,526	-44%	-$254K	﹤0.01%	2196
2021 Q4	$778K	Buy	10,273 +4,179	+69%	+$328K	﹤0.01%	2786
2021 Q3	$547K	Buy	+6,094	New	+$652K	﹤0.01%	3171

Other funds holding DMRA

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return

RCP

Remedium Capital Partners Fort Lauderdale, Florida $281M AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

Two Sigma Investments's DMRA Position: Q4 2025 in Review

Two Sigma Investments sold out of Damora Therapeutics, Inc. Ordinary Shares (DMRA) in Q4 2025, closing a stake of 20,296 shares — an estimated $75.5K sold.

Two Sigma Investments first reported a position in DMRA in Q3 2021 and held it in 9 quarters. The position peaked at $778K in Q4 2021. 18 funds tracked by Wall St. Rank hold DMRA as of Q4 2025.

Two Sigma Investments reported no remaining Damora Therapeutics, Inc. Ordinary Shares position as of Q4 2025 after selling out during the quarter.
Two Sigma Investments sold 20,296 Damora Therapeutics, Inc. Ordinary Shares shares in Q4 2025, an estimated $75.5K.
Two Sigma Investments first reported a position in Damora Therapeutics, Inc. Ordinary Shares in Q3 2021 and held it in 9 quarters.
Two Sigma Investments's Damora Therapeutics, Inc. Ordinary Shares position peaked at $778K in Q4 2021.
18 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q4 2025.

Based on Two Sigma Investments's 13F filing for Q4 2025, filed 17 Feb 2026.